FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Nov 22, 2019
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on November 22, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma Inc.
- Inspection Date
- November 22, 2019
- Product Type
- Biologics
View Company Profile
ID · a2dbaa40-3a45-454e-8b30-c2009070dcd1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110732
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.10(b)Form and manner of educational material
- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 19, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2017 | Not classified | Cincinnati District Office |
Other documents for CSL Plasma Inc.
- FDA Inspection 1158204 - 2021-11-19
- FDA Inspection 1024324 - 2017-07-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.